Q9950 HCPCS code: Injection, sulfur hexafluoride lipid microspheres, per ml
Q9950 is the HCPCS Level II code for injection, sulfur hexafluoride lipid microspheres, per ml. In 2024 Medicare paid an average of $14.24 per service for Q9950 across 15,518 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 5 per day on outpatient hospital claims. Medicare volume fell 6% from 2022 to 2024 (16,500 to 15,518 services). In 2024, about 615 clinicians billed Medicare for Q9950 for 3,760 beneficiaries; Texas, Illinois, Washington accounted for 40% of services.
Code details
| Field | Value |
|---|---|
| Section | Q codes — Temporary codes |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 57 |
| BETOS category | I1F |
| Added | 2016-01-01 |
| Last action effective | 2024-01-01 |
Who bills Q9950 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 615 |
| Medicare beneficiaries | 3,760 |
| States with claims | 28 |
| Share of services in top 3 states (Texas, Illinois, Washington) | 40% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for Q9950, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 16,500 | 4,290 | $18.37 | $14.33 |
| 2023 | 16,492 | 4,269 | $18.16 | $14.16 |
| 2024 | 15,518 | 3,760 | $18.42 | $14.24 |
States with the most Q9950 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Texas | 3,391 | $14.02 |
| Illinois | 1,696 | $14.58 |
| Washington | 1,077 | $14.21 |
| Missouri | 931 | $14.63 |
| North Carolina | 855 | $13.48 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 5 | CMS Policy |
| practitioner claims | 5 | CMS Policy |
Medicare policy articles for this code
- A58503: Billing and Coding: Echocardiography for Myocardial Perfusion (Palmetto GBA (MAC - Part A, MAC - Part B))
Covered diagnoses (108 ICD-10-CM codes)
The diagnoses most often listed as covered in the policy articles above:
| ICD-10-CM | Diagnosis | Articles listing it |
|---|---|---|
| I20.0 | Unstable angina | 1 |
| I20.1 | Angina pectoris with documented spasm | 1 |
| I20.81 | Angina pectoris with coronary microvascular dysfunction | 1 |
| I20.89 | Other forms of angina pectoris | 1 |
| I20.9 | Angina pectoris, unspecified | 1 |
| I21.01 | ST elevation (STEMI) myocardial infarction involving left main coronary artery | 1 |
| I21.02 | ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery | 1 |
| I21.09 | ST elevation (STEMI) myocardial infarction involving other coronary artery of anterior wall | 1 |
| I21.11 | ST elevation (STEMI) myocardial infarction involving right coronary artery | 1 |
| I21.19 | ST elevation (STEMI) myocardial infarction involving other coronary artery of inferior wall | 1 |
Showing 10 of 108. The full list, non-covered diagnoses and CSV export are in Caduvo.
What changed for Q9950
- 2016-01-01: Q9950 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code Q9950?
Q9950 is the HCPCS Level II code for injection, sulfur hexafluoride lipid microspheres, per ml. Short descriptor: "Inj sulf hexa lipid microsph".
How much does Medicare pay for Q9950?
In 2024, the average Medicare payment was $14.24 per service (average allowed $18.42).
Does Medicare cover Q9950?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
Which diagnoses support coverage for Q9950?
Medicare policy articles that cite Q9950 list 108 covered ICD-10-CM diagnosis codes across 1 article. The most cited include I20.0 (Unstable angina), I20.1 (Angina pectoris with documented spasm), I20.81 (Angina pectoris with coronary microvascular dysfunction). A listed diagnosis is necessary but not sufficient; the policy's other criteria still apply.
How many units of Q9950 can be billed per day?
5 on outpatient hospital claims; 5 on practitioner claims (NCCI medically unlikely edits).
Related Q99 codes
- Q9951 — Low osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml
- Q9953 — Injection, iron-based magnetic resonance contrast agent, per ml
- Q9954 — Oral magnetic resonance contrast agent, per 100 ml
- Q9955 — Injection, perflexane lipid microspheres, per ml
- Q9956 — Injection, octafluoropropane microspheres, per ml
- Q9957 — Injection, perflutren lipid microspheres, per ml
- Q9958 — High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml
- Q9959 — High osmolar contrast material, 150-199 mg/ml iodine concentration, per ml
- Q9960 — High osmolar contrast material, 200-249 mg/ml iodine concentration, per ml
- Q9961 — High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml
- Q9962 — High osmolar contrast material, 300-349 mg/ml iodine concentration, per ml
- Q9963 — High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under Q9950
- Watch Q9950 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for Q9950
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.